| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 10 4521-4524, Copyright © 1995 by American Association of Immunologists
CUTTING EDGE |
SJ Khoury, E Akalin, A Chandraker, LA Turka, PS Linsley, MH Sayegh and WW Hancock
Multiple Sclerosis Unit, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
We studied the contribution of the CD28-B7 costimulatory T cell activation pathway to the pathogenesis of experimental autoimmune encephalomyelitis in the Lewis rat model. Systemic administration of CTLA4Ig suppressed clinical disease and was effective even when CTLA4Ig was delayed until day 10 postimmunization, a time when pathologic disease is evident. This protection was not reversible by systemic administration of high doses of IL-2. Detailed immunohistologic studies showed that CTLA4Ig therapy resulted in suppression of the inflammatory response with inhibition of Th1 (IL-2 and IFN-gamma) and sparing of Th2 (IL-4, IL-10, and IL-13) cytokines in the central nervous system. These results indicate that the CD28-B7 T cell costimulatory pathway plays an important role in experimental autoimmune encephalomyelitis, a Th1- mediated disease, and suggest that blockade of this costimulatory pathway protects against active disease by causing a state of immune deviation towards Th2 function. The ability of CTLA4Ig to treat animals with pathologically established disease may have important clinical implications for patients with multiple sclerosis.
This article has been cited by other articles:
|
|
 |
|
  W. Elyaman, P. Kivisakk, J. Reddy, T. Chitnis, K. Raddassi, J. Imitola, E. Bradshaw, V. K. Kuchroo, H. Yagita, M. H. Sayegh, et al. Distinct Functions of Autoreactive Memory and Effector CD4+ T Cells in Experimental Autoimmune Encephalomyelitis Am. J. Pathol., August 1, 2008; 173(2): 411 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. O'Neill, Y. Cao, K. M. Hamel, P. D. Doodes, G. Hutas, and A. Finnegan Expression of CD80/86 on B Cells Is Essential for Autoreactive T Cell Activation and the Development of Arthritis J. Immunol., October 15, 2007; 179(8): 5109 - 5116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kobayashi, H. Kobayashi, L. Gu, T. Malefyt, and T. J. Siahaan Antigen-Specific Suppression of Experimental Autoimmune Encephalomyelitis by a Novel Bifunctional Peptide Inhibitor J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 879 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Wei, J. Anolik, A. Cappione, B. Zheng, A. Pugh-Bernard, J. Brooks, E.-H. Lee, E. C. B. Milner, and I. Sanz A New Population of Cells Lacking Expression of CD27 Represents a Notable Component of the B Cell Memory Compartment in Systemic Lupus Erythematosus J. Immunol., May 15, 2007; 178(10): 6624 - 6633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Linhart, S. Bigenzahn, A. Hartl, C. Lupinek, J. Thalhamer, R. Valenta, and T. Wekerle Costimulation Blockade Inhibits Allergic Sensitization but Does Not Affect Established Allergy in a Murine Model of Grass Pollen Allergy J. Immunol., March 15, 2007; 178(6): 3924 - 3931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Ndejembi, J. R. Teijaro, D. S. Patke, A. W. Bingaman, M. R. Chandok, A. Azimzadeh, S. G. Nadler, and D. L. Farber Control of Memory CD4 T Cell Recall by the CD28/B7 Costimulatory Pathway J. Immunol., December 1, 2006; 177(11): 7698 - 7706. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nierkens, M. Aalbers, M. Bol, R. Bleumink, P. van Kooten, L. Boon, and R. Pieters Differential Requirement for CD28/CTLA-4-CD80/CD86 Interactions in Drug-Induced Type 1 and Type 2 Immune Responses to Trinitrophenyl-Ovalbumin J. Immunol., September 15, 2005; 175(6): 3707 - 3714. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Odobasic, A. R. Kitching, T. J. Semple, J. R. Timoshanko, P. G. Tipping, and S. R. Holdsworth Glomerular Expression of CD80 and CD86 Is Required for Leukocyte Accumulation and Injury in Crescentic Glomerulonephritis J. Am. Soc. Nephrol., July 1, 2005; 16(7): 2012 - 2022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Axtell, M. S. Webb, S. R. Barnum, and C. Raman Cutting Edge: Critical Role for CD5 in Experimental Autoimmune Encephalomyelitis: Inhibition of Engagement Reverses Disease in Mice J. Immunol., September 1, 2004; 173(5): 2928 - 2932. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Dall'Era and J Davis CTLA4Ig: a novel inhibitor of costimulation Lupus, May 1, 2004; 13(5): 372 - 376. [Abstract] [PDF]
|
|
|
|
|
|
S. B. Conant and R. H. Swanborg Autoreactive T Cells Persist in Rats Protected against Experimental Autoimmune Encephalomyelitis and Can Be Activated through Stimulation of Innate Immunity J. Immunol., May 1, 2004; 172(9): 5322 - 5328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Imitola, E. Y. Snyder, and S. J. Khoury Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis Physiol Genomics, August 15, 2003; 14(3): 171 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Wells, Q.-H. Liu, B. Hondowicz, J. Zhang, L. A. Turka, and B. D. Freedman Regulation of T Cell Activation and Tolerance by Phospholipase C{gamma}-1-Dependent Integrin Avidity Modulation J. Immunol., April 15, 2003; 170(8): 4127 - 4133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Totsuka, T. Kanai, K. Uraushihara, R. Iiyama, M. Yamazaki, H. Akiba, H. Yagita, K. Okumura, and M. Watanabe Therapeutic effect of anti-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis Am J Physiol Gastrointest Liver Physiol, April 1, 2003; 284(4): G595 - G603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Srinivasan, I. E. Gienapp, S. S. Stuckman, C. J. Rogers, S. D. Jewell, P. T. P. Kaumaya, and C. C. Whitacre Suppression of Experimental Autoimmune Encephalomyelitis Using Peptide Mimics of CD28 J. Immunol., August 15, 2002; 169(4): 2180 - 2188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Lang, P. Nguyen, R. Peach, W. C. Gause, and C. S. Via In Vivo CD86 Blockade Inhibits CD4+ T Cell Activation, Whereas CD80 Blockade Potentiates CD8+ T Cell Activation and CTL Effector Function J. Immunol., April 15, 2002; 168(8): 3786 - 3792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Appleman, A. A. F. L. van Puijenbroek, K. M. Shu, L. M. Nadler, and V. A. Boussiotis CD28 Costimulation Mediates Down-Regulation of p27kip1 and Cell Cycle Progression by Activation of the PI3K/PKB Signaling Pathway in Primary Human T Cells J. Immunol., March 15, 2002; 168(6): 2729 - 2736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-h. Ogawa, G. Nagamatsu, M. Watanabe, S. Watanabe, T. Hayashi, S. Horita, K. Nitta, H. Nihei, K. Tezuka, and R. Abe Opposing Effects of Anti-Activation-Inducible Lymphocyte- Immunomodulatory Molecule/Inducible Costimulator Antibody on the Development of Acute Versus Chronic Graft-Versus-Host Disease J. Immunol., November 15, 2001; 167(10): 5741 - 5748. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shao, M.-D. Woon, S. Nakamura, J.-H. Sohn, P. A. Morton, N. S. Bora, and H. J. Kaplan Requirement of B7-Mediated Costimulation in the Induction of Experimental Autoimmune Anterior Uveitis Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2016 - 2021. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Srinivasan, R. M. Wardrop, I. E. Gienapp, S. S. Stuckman, C. C. Whitacre, and P. T. P. Kaumaya A Retro-Inverso Peptide Mimic of CD28 Encompassing the MYPPPY Motif Adopts a Polyproline Type II Helix and Inhibits Encephalitogenic T Cells In Vitro J. Immunol., July 1, 2001; 167(1): 578 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Jones, C. C. H. Kwok, and A. W. C. Kung Effect of Radioactive Iodine Therapy on Cytokine Production in Graves' Disease: Transient Increases in Interleukin-4 (IL-4), IL-6, IL-10, and Tumor Necrosis Factor-{alpha}, with Longer Term Increases in Interferon-{gamma} Production J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4106 - 4110. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. D DICK and J. D ISAACS Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium Br. J. Ophthalmol., November 1, 1999; 83(11): 1230 - 1234. [Full Text]
|
|
|
|
 |
|
 M. A. POTTER and P. L. CHANG Review-The Use of Immunosuppressive Agents to Prevent Neutralizing Antibodies Against a Transgene Product Ann. N.Y. Acad. Sci., June 18, 1999; 875(1): 159 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Oliveira-dos-Santos, A. Ho, Y. Tada, J. J. Lafaille, S. Tonegawa, T. W. Mak, and J. M. Penninger CD28 Costimulation Is Crucial for the Development of Spontaneous Autoimmune Encephalomyelitis J. Immunol., April 15, 1999; 162(8): 4490 - 4495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Judge, Z. Wu, X.-G. Zheng, A. H. Sharpe, M. H. Sayegh, and L. A. Turka The Role of CD80, CD86, and CTLA4 in Alloimmune Responses and the Induction of Long-Term Allograft Survival J. Immunol., February 15, 1999; 162(4): 1947 - 1951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Higgins, S. A. C. McDonald, N. Whittle, N. Crockett, J. G. Shields, and T. T. MacDonald Regulation of T Cell Activation In Vitro and In Vivo by Targeting the OX40-OX40 Ligand Interaction: Amelioration of Ongoing Inflammatory Bowel Disease with an OX40-IgG Fusion Protein, But Not with an OX40 Ligand-IgG Fusion Protein J. Immunol., January 1, 1999; 162(1): 486 - 493. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Niimi, T. C. Pearson, C. P. Larsen, D. Z. Alexander, D. Hollenbaugh, A. Aruffo, P. S. Linsley, E. Thomas, K. Campbell, W. C. Fanslow, et al. The Role of the CD40 Pathway in Alloantigen-Induced Hyporesponsiveness In Vivo J. Immunol., November 15, 1998; 161(10): 5331 - 5337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Issazadeh, V. Navikas, M. Schaub, M. Sayegh, and S. Khoury Kinetics of Expression of Costimulatory Molecules and Their Ligands in Murine Relapsing Experimental Autoimmune Encephalomyelitis In Vivo J. Immunol., August 1, 1998; 161(3): 1104 - 1112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Koch, S. Choksi, L. Marcucci, and R. Korngold A Synthetic CD4-CDR3 Peptide Analog Enhances Skin Allograft Survival Across a MHC Class II Barrier J. Immunol., July 1, 1998; 161(1): 421 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Bashian, C. M. Braun, S.-K. Huang, A. Kagey-Sobotka, L. M. Lichtenstein, and D. M. Essayan Differential Regulation of Human, Antigen-specific Th1 and Th2 Responses by the B-7 Homologues, CD80 and CD86 Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 235 - 242. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
